Biochemical recurrence (BCR) refers to the situation that after PCa patients receive radical treatments (such as radical prostatectomy, radical radiotherapy, etc.), the level of serum prostate-specific antigen (PSA) rises above a certain critical value, and it is generally considered that biochemical recurrence has occurred5. This evidence concerns the gene KLK3 and posterior cortical atrophy.